Surface Oncology - Ownership and Business Overview

Life ScienceCompany

Surface Oncology Ownership

Who owns Surface Oncology?

.

Was Surface Oncology formerly PE-backed?

Yes. Surface Oncology was formerly owned by 1 private investor.

Surface Oncology Business Overview

Where is Surface Oncology headquartered?

Surface Oncology is headquartered in Cambridge, Massachusetts.

What is Surface Oncology’s revenue?

Surface Oncology disclosed revenue of 30M USD for 2022 and 3M USD for 2021.

What sector is Surface Oncology in?

Surface Oncology is a life science company.

When was Surface Oncology founded?

Surface Oncology was founded in 2014.

Life Science M&A Summary in

Join Mergr to view all 0 acquisitions of life science companies in , including .

Surface Oncology

Surface Oncology, Inc.

50 Hampshire Street, 8th Floor,
Cambridge, Massachusetts 02139
United States,
(617) 714-4096
www.surfaceoncology.com

Surface Oncology is an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment. Its pipeline includes two wholly-owned programs: SRF388, a Phase 2 program targeting IL-27, and SRF114, a Phase 1 program that selectively depletes regulatory T cells in the tumor microenvironment via targeting CCR8. Surface Oncology was founded in 2014 and is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 209,235
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.